Cargando…

Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Amblyomma americanum on dogs

BACKGROUND: The lone star tick, Amblyomma americanum, infests dogs and cats in North America and is the vector of the pathogens that cause monocytic and granulocytic ehrlichiosis in dogs and humans. A parasiticide’s speed of kill is important to minimize the direct and deleterious effects of tick in...

Descripción completa

Detalles Bibliográficos
Autores principales: Six, Robert H., Everett, William R., Chapin, Sara, Mahabir, Sean P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761219/
https://www.ncbi.nlm.nih.gov/pubmed/26897175
http://dx.doi.org/10.1186/s13071-016-1378-8
_version_ 1782416953701302272
author Six, Robert H.
Everett, William R.
Chapin, Sara
Mahabir, Sean P.
author_facet Six, Robert H.
Everett, William R.
Chapin, Sara
Mahabir, Sean P.
author_sort Six, Robert H.
collection PubMed
description BACKGROUND: The lone star tick, Amblyomma americanum, infests dogs and cats in North America and is the vector of the pathogens that cause monocytic and granulocytic ehrlichiosis in dogs and humans. A parasiticide’s speed of kill is important to minimize the direct and deleterious effects of tick infestation and especially to reduce the risk of transmission of tick-borne pathogens. In this study, speed of kill of a novel orally administered isoxazoline parasiticide, sarolaner (Simparica(™) chewable tablets), against A. americanum on dogs was evaluated and compared with afoxolaner (NexGard(®)) for 5 weeks following a single oral dose. METHODS: Based on pretreatment tick counts, 24 dogs were randomly allocated to treatment with sarolaner (2 to 4 mg/kg), afoxolaner (2.5 to 6.8 mg/kg) or a placebo. Dogs were examined and live ticks counted at 8, 12, and 24 h after treatment and subsequent re-infestations on Days 7, 14, 21, 28, and 35. Efficacy was determined at each time point relative to counts for placebo dogs. RESULTS: A single oral dose of sarolaner provided 100 % efficacy within 24 h of treatment, and consistently provided >90 % efficacy against subsequent weekly re-infestations with ticks to Day 28. Significantly more live ticks were recovered from afoxolaner-treated dogs than from sarolaner-treated dogs at 24 h after infestation from Day 7 through Day 35 (P ≤ 0.0247). At 24 h, efficacy of afoxolaner declined to less than 90 % from Day 14 to the end of the study. There were no adverse reactions to treatment. CONCLUSIONS: In this controlled laboratory evaluation, sarolaner had a faster speed of kill against A. americanum ticks than afoxolaner. The rapid and consistent kill of ticks by sarolaner within 24 h after a single oral dose over 28 days, suggests this treatment will provide highly effective and reliable control of ticks over the entire treatment interval, and could help reduce the risk of transmission of tick-borne pathogens by A. americanum.
format Online
Article
Text
id pubmed-4761219
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47612192016-02-21 Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Amblyomma americanum on dogs Six, Robert H. Everett, William R. Chapin, Sara Mahabir, Sean P. Parasit Vectors Research BACKGROUND: The lone star tick, Amblyomma americanum, infests dogs and cats in North America and is the vector of the pathogens that cause monocytic and granulocytic ehrlichiosis in dogs and humans. A parasiticide’s speed of kill is important to minimize the direct and deleterious effects of tick infestation and especially to reduce the risk of transmission of tick-borne pathogens. In this study, speed of kill of a novel orally administered isoxazoline parasiticide, sarolaner (Simparica(™) chewable tablets), against A. americanum on dogs was evaluated and compared with afoxolaner (NexGard(®)) for 5 weeks following a single oral dose. METHODS: Based on pretreatment tick counts, 24 dogs were randomly allocated to treatment with sarolaner (2 to 4 mg/kg), afoxolaner (2.5 to 6.8 mg/kg) or a placebo. Dogs were examined and live ticks counted at 8, 12, and 24 h after treatment and subsequent re-infestations on Days 7, 14, 21, 28, and 35. Efficacy was determined at each time point relative to counts for placebo dogs. RESULTS: A single oral dose of sarolaner provided 100 % efficacy within 24 h of treatment, and consistently provided >90 % efficacy against subsequent weekly re-infestations with ticks to Day 28. Significantly more live ticks were recovered from afoxolaner-treated dogs than from sarolaner-treated dogs at 24 h after infestation from Day 7 through Day 35 (P ≤ 0.0247). At 24 h, efficacy of afoxolaner declined to less than 90 % from Day 14 to the end of the study. There were no adverse reactions to treatment. CONCLUSIONS: In this controlled laboratory evaluation, sarolaner had a faster speed of kill against A. americanum ticks than afoxolaner. The rapid and consistent kill of ticks by sarolaner within 24 h after a single oral dose over 28 days, suggests this treatment will provide highly effective and reliable control of ticks over the entire treatment interval, and could help reduce the risk of transmission of tick-borne pathogens by A. americanum. BioMed Central 2016-02-19 /pmc/articles/PMC4761219/ /pubmed/26897175 http://dx.doi.org/10.1186/s13071-016-1378-8 Text en © Six et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Six, Robert H.
Everett, William R.
Chapin, Sara
Mahabir, Sean P.
Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Amblyomma americanum on dogs
title Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Amblyomma americanum on dogs
title_full Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Amblyomma americanum on dogs
title_fullStr Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Amblyomma americanum on dogs
title_full_unstemmed Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Amblyomma americanum on dogs
title_short Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Amblyomma americanum on dogs
title_sort comparative speed of kill of sarolaner (simparica(™)) and afoxolaner (nexgard(®)) against induced infestations of amblyomma americanum on dogs
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761219/
https://www.ncbi.nlm.nih.gov/pubmed/26897175
http://dx.doi.org/10.1186/s13071-016-1378-8
work_keys_str_mv AT sixroberth comparativespeedofkillofsarolanersimparicaandafoxolanernexgardagainstinducedinfestationsofamblyommaamericanumondogs
AT everettwilliamr comparativespeedofkillofsarolanersimparicaandafoxolanernexgardagainstinducedinfestationsofamblyommaamericanumondogs
AT chapinsara comparativespeedofkillofsarolanersimparicaandafoxolanernexgardagainstinducedinfestationsofamblyommaamericanumondogs
AT mahabirseanp comparativespeedofkillofsarolanersimparicaandafoxolanernexgardagainstinducedinfestationsofamblyommaamericanumondogs